Trade

Watchlist

Portfolio

Message

Set Alert

BSE LIVE NSE LIVE 26 Aug, 2025 12:21 Volume Todays L/H More ×

Reported Standalone quarterly numbers for Astec Lifesciences are:

Net Sales at Rs 73.72 crore in September 2025 down 25.19% from Rs. 98.55 crore in September 2024.

Quarterly Net Loss at Rs. 24.45 crore in September 2025 up 36.61% from Rs. 38.57 crore in September 2024.

EBITDA stands negative at Rs. 5.58 crore in September 2025 up 68.56% from Rs. 17.75 crore in September 2024.

Astec Life shares closed at 660.05 on October 30, 2025 (NSE) and has given -3.77% returns over the last 6 months and -39.27% over the last 12 months.

Astec Lifesciences Standalone Quarterly Results in Rs. Cr. Sep'25 Jun'25 Sep'24 Net Sales/Income from operations 73.72 91.

See Full Page